Skip to main content
Veterinary Medicines

GLUCOCOFEIN® solutio pro injectionibus

Authorised
  • Glucose monohydrate
  • CAFFEINE AND SODIUM BENZOATE

Product identification

Medicine name:
ГЛЮКОКОФЕИН® инжекционен разтвор
GLUCOCOFEIN® solutio pro injectionibus
Active substance:
  • Glucose monohydrate
  • CAFFEINE AND SODIUM BENZOATE
Target species:
  • Cattle
  • Horse
  • Sheep
  • Goat
  • Dog
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Glucose monohydrate
    20.00
    gram(s)
    /
    100.00
    millilitre(s)
  • CAFFEINE AND SODIUM BENZOATE
    0.80
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
    • Horse
    • Sheep
    • Goat
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC05BB56
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetprom AD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetprom AD
Responsible authority:
  • Bulgarian Agency For Food Safety
Authorisation number:
  • 0022-2513/03.04.2015
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 2/03/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 2/03/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 2/03/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."